0001209191-23-041857.txt : 20230707
0001209191-23-041857.hdr.sgml : 20230707
20230707180824
ACCESSION NUMBER: 0001209191-23-041857
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160104
FILED AS OF DATE: 20230707
DATE AS OF CHANGE: 20230707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mates Sharon
CENTRAL INDEX KEY: 0001585699
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 231077889
MAIL ADDRESS:
STREET 1: C/O INTRA-CELLULAR THERAPIES, INC.
STREET 2: 3960 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0407
4/A
2016-01-04
2016-01-06
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001585699
Mates Sharon
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
1
1
0
0
Chairman, President & CEO
0
Stock Option (right to buy)
53.63
2016-01-04
4
A
0
86003
0.00
A
2017-01-04
2026-01-04
Common Stock
86003
86003
D
The Stock Option vests as to one third of the shares on January 4, 2017, one third of the shares on January 4, 2018 and one third of the shares on January 4, 2019.
This Form 4/A is being filed solely to correct an error in the number of shares underlying the stock option granted on January 4, 2016.
/s/ Lawrence J. Hineline, Attorney-in-fact
2023-07-07